Prospective vs Retrospective Sample Collection

When choosing between prospective vs retrospective sample collection, it’s essential to consider how each method impacts your access to samples collected exactly as you need.

Comparing Prospective vs Retrospective Collection Methods

A diagram illustrating the retrospective collection method

Retrospective Collection

Retrospective collection is the traditional method used in biobanking, where samples are collected and stored ahead of time in anticipation of future research requests. The main advantage of this approach is the immediate availability of well-annotated samples, which may have taken months or even years to collect and prepare.

However, this method has limitations. Since samples are collected in advance, it follows a ‘one size fits all’ approach, which may not align with the specific needs of all requesters. This can be inefficient and costly, especially if many stored samples are never used. Additionally, stockpiling or ‘biohoarding’ samples is considered unethical and should be avoided.

Prospective collection

In contrast, prospective collection occurs only after a request has been made. This approach is essential when fresh, viable tissue is required or when the needed samples are not already available in the biobank. One of the key benefits of prospective collection is the customization it offers. The requester can specify:

  • Which types of samples are collected
  • Which collection protocols are followed

This tailored approach ensures that the samples perfectly align with your research needs, providing greater flexibility and precision compared to retrospective collection.

A diagram illustrating the prospective collection method

A Video Comparing Prospective vs Retrospective Collection

Recommendations For Prospective Collection

If you believe prospective collection is the best option for your research, it’s important to plan ahead. Start by contacting an academic biobank and working with them to initiate your collection. On the Biosample Hub platform, over 75% of biobanks offer prospective collection services, making it easy to tailor sample collection to your exact specifications.

References

Catchpoole D. ‘Biohoarding’: treasures not seen, stories not told. J Health Serv Res Policy. 2016 Apr;21(2):140-2. doi: 10.1177/1355819615599014. Epub 2015 Aug 5. PMID: 26248620.

Grizzle WE, Sexton KC. Commentary on Improving Biospecimen Utilization by Classic Biobanks: Identifying Past and Minimizing Future Mistakes. Biopreserv Biobank. 2019 Jun;17(3):243-247. doi: 10.1089/bio.2018.0080. Epub 2018 Dec 1. PMID: 30508389; PMCID: PMC6588113.

Biosample Hub logo

 The Biosample Hub platform enables biotech and pharma companies to access reliable clinical samples and data